2026 KASBP NJ/NY Chapter biopharma Conference
From Unmet Need to
Patient Access
A One-Day Journey of Drug Development
Co-Hosted with SK Biopharmaceuticals (XCOPRI Case Study)
Hyatt Place Fort Lee / George Washington Bridge
October 10, 2026
Conference Vision
Innovation does not end with discovery. A medicine reaches patients only when science, clinical development, regulation, and commercialization come together.
Our Speakers
Session I - Creating Innovation: Discovery & R&D
Libor Velisek
Hai Sun
Vice Chair of Clinical Operations
Haein Shin
Assistant Dean for Basic Medical Sciences
New York Medical College
Rutgers Robert Wood Johnson Medical School
Vice President, Corporate Portfolio
SK Biopharmaceuticals
Session II - Translating Innovation: Clinical Development & Regulatory Approval
Sangmok Chung
Sunita Misra
President
NatureCell America
Chief Medical Officer
SK Life Science Inc.
Session III - Delivering Innovation: Commercialization, Market Access & Beyond
Keunyong Cho
Kristina Stracco
Woojin Choi
Vice President, Commercial Operations
SK Life Science Inc.
Vice President, Market Access
SK Life Science Inc.
Vice President, Head of Business Development
SK Life Science Inc.
Closing Keynote - Reflections on Building a Global Biopharma Company
Donghoon Lee
Chief Executive Officer
SK Biopharmaceuticals & SK Life Science
Program
Venue & Directions
Contact: njny.president@kasbp.org